Fourcompany Co., Ltd. – Trademark Portfolio
Entity Type: 03
Fourcompany Co., Ltd. owns a portfolio of 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ABIB, NAMING, and BOLD FORMULA. Of these, 4 are registered and 1 is pending. The portfolio spans 6 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 3 (Cosmetics & Cleaning). Headquartered in Seoul.
3fl.14 Baekjegobunro 9-gil Sonpagu
Seoul 05562 , KR
Showing of trademarks Trademarks
Trademark Classifications
Fourcompany Co., Ltd.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Fourcompany Co., Ltd. have?
Fourcompany Co., Ltd. has 12 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 7 abandoned.
What trademark classes does Fourcompany Co., Ltd. file in?
Fourcompany Co., Ltd. files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 8 (Hand Tools), Class 21 (Housewares), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.
What are Fourcompany Co., Ltd.'s most well-known trademarks?
Fourcompany Co., Ltd.'s registered trademark portfolio includes well-known marks such as ABIB, NAMING, and BOLD FORMULA. These are among 4 currently registered trademarks in the portfolio.
What is Fourcompany Co., Ltd.'s trademark registration success rate?
Fourcompany Co., Ltd. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.